Recent examples include Oxytrol
for Women (Merck) for the O-T-C treatment of overactive bladder; Nasacort 24HR (Sanofi) intranasal steroid for the treatment of allergies; and two intranasal steroid switches, Flonase Allergy Relief (GlaxoSmithKline) and Rhinocort Allergy Spray (Johnson & Johnson).
A few years ago, she was the lead project manager and consultant on the switch of Oxytrol
The bladder control drug oxybutynin, which was partially switched in 2013 as an OTC transdermal patch marketed by Merck as Oxytrol
for Women, is another drug that's being discussed.
"These are Oxytrol
for Women (Merck) in September 2013 for the O-T-C treatment of overactive bladder and Nasacort 24HR (Sanofi) intranasal steroid for the treatment of allergies in 2014.
According to Actavis, for the non-generic business, the firm will continue to promote and distribute branded medicines in the range including but not limited to products such as Actonel and Oxytrol
. The Irish company will also continue to provide Botox, eye-care products and all other heritage Allergan products.
Importantly, for the non-generic business, Actavis will continue to promote and distribute branded medicines in the portfolio including but not limited to products such as Actonel and Oxytrol
Drugs known as anticholinergics (such as Ditropan, Detrol, Vesicare, Enablex, Gelnique, Oxytrol
and Toviaz) suppress involuntary bladder contractions to help with urgency, frequency and urgency-related leakage.
patch, previously a prescription-only drug, will become available this fall as an over-the-counter product for women with that condition.
In January, the FDA approved an over-the-counter oxybutynin patch (Oxytrol
) for use in women with OAB.
Oxybutynin is available in tablets (Ditropan), extended-release tablets (Ditropan XL), patch (Oxytrol
) and gel form (Gelnique).
On Friday, Oxytrol
was approved for use by women over the age of 18.
Oxybutynin is available in a transdermal patch, but only as a trade formulation (Oxytrol
), which does not include any pediatric information on the label other than that safety and efficacy in pediatric patients has not been established.